Montelukast
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (National)
4.9M
NHS Cost
£7.5M
Practices
7,145
Avg per Practice
685
Overview
Montelukast is prescribed by 7,145 GP practices across England. In the last 12 months, 4,892,355 items were prescribed at a total cost of £7,468,548 to the NHS. It is classified under BNF Chapter Respiratory System, Section Cromoglycate, leukotriene and phosphodesterase type-4 inhib.
Monthly Prescribing Trend
Jun 2026
418,746
Jun 2026
393,448
Jun 2026
426,308
Jun 2026
402,954
Jun 2026
397,471
Jun 2026
420,133
Jun 2026
404,030
Jun 2026
416,008
Jun 2026
424,604
Jun 2026
376,422
Jun 2026
401,020
Jun 2026
403,321
Prescribing by Area
| Area | Items | Practices | Avg/Practice | vs National |
|---|---|---|---|---|
| S | 186.3K | 173 | 1,077 | +57.2% ▲ |
| B | 174.4K | 270 | 646 | -5.7% ▼ |
| NE | 148.4K | 140 | 1,060 | +54.8% ▲ |
| PE | 130.9K | 95 | 1,378 | +101.2% ▲ |
| M | 128.4K | 179 | 717 | +4.8% ▲ |
| NR | 104.9K | 75 | 1,399 | +104.3% ▲ |
| NG | 101.3K | 139 | 729 | +6.4% ▲ |
| TS | 99.6K | 74 | 1,347 | +96.7% ▲ |
| NN | 92.8K | 68 | 1,364 | +99.3% ▲ |
| E | 90.1K | 144 | 626 | -8.6% ▼ |
| ST | 88.9K | 86 | 1,034 | +51.0% ▲ |
| DN | 85.3K | 88 | 970 | +41.6% ▲ |
| LS | 84.1K | 91 | 925 | +35.0% ▲ |
| L | 80.2K | 149 | 538 | -21.4% ▼ |
| LE | 79.5K | 127 | 626 | -8.6% ▼ |
| PO | 74.7K | 65 | 1,150 | +67.9% ▲ |
| BD | 74.3K | 63 | 1,179 | +72.2% ▲ |
| CV | 73.8K | 110 | 671 | -2.1% ▼ |
| DE | 70.5K | 82 | 860 | +25.6% ▲ |
| GL | 70.1K | 67 | 1,047 | +52.9% ▲ |
Top Prescribing Practices
| Practice | Items |
|---|---|
| MODALITY PARTNERSHIP (AWC) | 9,079 |
| BAY MEDICAL GROUP | 7,998 |
| MIDLANDS MEDICAL PARTNERSHIP | 6,797 |
BNF Classification
- Chapter: Respiratory System
- Section: Cromoglycate, leukotriene and phosphodesterase type-4 inhib
- Paragraph: Leukotriene receptor antagonists
Related drugs in this section
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.